Aftermarket Performance

November 2004
Investment Dealers' Digest;11/29/2004, Vol. 70 Issue 46, p24
Trade Publication
This article presents information on the performance of several initial public offerings in the U.S.


Related Articles

  • The IPO 100.  // Investment Dealers' Digest;11/29/2004, Vol. 70 Issue 46, p23 

    This article presents information on the most recent 100 initial public offerings in the U.S.

  • By the numbers.  // njbiz;10/6/2014, Vol. 27 Issue 40, p1 

    The article presents the number of initial public offerings (IPO) through three quarters of 2014 in New Jersey.

  • IN THE PIPELINE.  // Investment Dealers' Digest;9/13/2004, Vol. 70 Issue 35, p16 

    This article focuses on the events related to the financial market of the United States that are in the offing. Stonemor Partner is going to bring its Initial Public Offering. Non-IPO list contains the names of Amedisys, Catapult Communications and Wheeling-Pittsburgh.

  • Who needs underwriters? Anand, Anita I.; Johnson, Lewis D. // Canadian Investment Review;Spring2004, Vol. 17 Issue 1, p45 

    Discusses the use of direct public offerings (DPO) and underwriters by business enterprises in Canada and the U.S. Efficiency of a DPO; Use of the Internet to complete securities offerings; Suggestions for replacing the verification function of an underwriter.

  • NEW STOCK ISSUES GO UP, UP, UP, AND WALL STREET CRIES: MORE! Norton, Rob // Fortune;10/18/1993, Vol. 128 Issue 9, p27 

    Focuses on the boom in the initial public offerings (IPOs) market in the U.S., as of October 18, 1993. Number of companies that have already registered $6 billion in IPOs with the Securities and Exchange Commission to be issued next year; Reason for market's strength; Diversity of companies...

  • Sarbanes-Oxley Costs Affect Smaller Companies the Most. Pomeroy, Ann // HR Magazine;Aug2006, Vol. 51 Issue 8, p14 

    The article presents the results of a study on the impact of Sarbanes-Oxley Act on companies in the U.S., conducted by law firm Foley & Lardner. Large companies paid more than $1 billion to become public in 2002. It found that before Sarbanes-Oxley was implemented, smaller companies paid an...

  • Targanta Seeks $86M In IPO For Antibiotic Development. Morrison, Trista // BioWorld Today;5/15/2007, Vol. 18 Issue 94, p1 

    The article reports on the planned initial public offering (IPO) of Cambridge, Massachusetts-based Targanta Therapeutics Corp. As the biotechnology firm prepares to file a new drug application for its antibiotic oritavancin in the first quarter of 2008, it has filed to raise $86.25 million in an...

  • Financings Roundup.  // BioWorld Today;10/10/2007, Vol. 18 Issue 197, p6 

    The article reports on the plan by Genoptix Inc. of Carlsbad, California to launch an initial public offering (IPO). The company has set a price range of $14 to $16 per share for its proposed IPO, which will include 5 million shares and an additional 750,000 shares to cover any overallotments....

  • Financings Roundup.  // BioWorld Today;10/10/2007, Vol. 18 Issue 197, p6 

    The article reports on the initial public offering (IPO) launched by MAP Pharmaceuticals Inc. of Mountain View, California. The company announced that its underwriters fully exercised their overallotment option by purchasing an additional 750,000 shares of common stock at $12 per share. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics